The association between postmenopausal osteoporosis and kidney-vacuity syndrome in traditional chinese medicine

American Journal of Chinese Medicine

Volumn 27, Issue 1, 1999, Pages 25-35

  Chen, Ya Yin ^a,b   Hsue, Yin Tzu ^a,c,d   Chang, Hen Hong ^a,d   Gee, Mei Jih ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

^d FENG CHIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; CHINESE MEDICINE; FEMALE; HUMAN; KIDNEY DISEASE; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; REGRESSION ANALYSIS; SYNDROME;

ADULT; AGED; BONE DENSITY; FEMALE; HUMANS; KIDNEY DISEASES; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; REGRESSION ANALYSIS; SYNDROME;

EID: 0032609580     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X99000057     Document Type: Article

References (25)

1. Cai, Xing-Ji. Study of bone mineral content and kidney deficiency. J Shandong college of traditional Chinese Med. 16(2): 52,1992.
2. Cai, Xing-Ji, Yang Zhang, and Shi-Lin Huang. Study of bone mineral content change in kidney deficiency patients. Chinese J. of Integrated Traditional & Western Med. 14(3): 154-155,1994.
3. Chen, Ya-Yin, Hen-Hong Chang, Yin-Tzu Hsue, and Mei-Jih Gee. The association between Preand post- menopausal females' bone mineral density and kidney vacuity syndrome in tradtional Chinese medicine. 67th Chinese Medical Physicians' Day conference, Taichung, Taiwan, 1997.
4. Daniel, R. and J. Mishell. Menopause, in: Endocrinology and Infertility. Chapter 40, Maple-Vail (ed.). St Louis: Mosby, 1987, p. 1082.
5. Delmas, P.D. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med. 91(suppl. Sb): 59s-63s, 1991.
6. Eriksen, E.F., D.S. Colvard, N.J. Berg, M.L. Grehman, K.G. Mann, T.C. Spelsberg and B.L. Riggs. Evidence of estrogen receptors in normal human osteoblast-Iike cells. Science 241(4861): 84-86,1988.
7. Gertz, B.J., P. Shao, D.A. Hanson, H. Quan, S.T. Harris, H.K. Genant, C.H. Chesnut III, and D.R. Eyre. Monitoring bone résorption in early postmenopausal women by an immunoassay for cross-linked collagen peptide in urine. J. Bone Miner Res. 9(2): 135-142, 1994.
8. Isaia, G., M. Mussetta, M. Di Stefano, A. Sciolla, S. Triolo, and G.M. Molinatti. Metabolic markers for the early diagnosis of postmenopausal osteoporosis. J. Endocrinol. Invest. 17: 771774, 1994.
9. Johnston, C.C., S.L. Hui, R.M. Witt, R. Appledorn, R.S. Baker and C. Longcope. Early menopausal changes in bone mass and sex steroids. J Clin. Endocrinol. Metab. 61: 905-911, 1985.
10. Kazuhiro, K., T. Masaaki, K. Kouichi, I. Tetsuo. Comparison of markers for bone formation and résorption in premenopausal and postmenopausal subjects, and osteoporosis patients. J Clin Endo Metab. 80: 2447-2450, 1995.
11. Lawrence, R. and K. Sundeep. Role of Biochemical Markers in assessment of osteoporosis. Acta. Orthop Scand (Suppl. 266) 66: 14-18, 1995.
12. Leon, S., H.G. Robert and G.K. Nathan. Menopause and postmenopausal hormone therapy. In: Clinical Gynecolgic Endocrinology and Infertility. 5th ed. M. Charles (ed.). Baltimore: Williams and Wilkins, 1994, Chapter 18, p. 589.
13. Lindsay, R. Osteoporosis and its relationship to estrogen. Contemp Obstet. Gynecol. 62:,201204, 1984.
14. Lindsay, R. and J. Tohme. Estrogen treatment of patients with established postmenopasual osteoporosis. Obstet. Gynecol. 76: 290-295, 1990.
15. Martin, B., Q. Per, F. Christian, J.R. Bente and C. Clans. Application of an enzyme immunoassay for a new marker of bone résorption (Crosslaps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin. Endocrinol. Metab. 80(3): 864-868, 1995.
16. Oursler, M.J., P. Osdoby, J. Pyfferoen, B.L. Riggs and T.C. Spellsberg. Avian osteoblasts as estrogen target cells. ProcNatlAcad Sei USA 88(6): 6613-6617, 1990.
17. Pierre, D.D. Biochemical markers for assessment of bone turnover, in: Osteoporosis: etiology, diagnosis, and management. 2nd ed. B.L. Riggs and L.J. Melton III (eds.). Philadelphia: Lippincolt-Raven, 1995, pp. 319-333.
18. Qian, Tang and Zhi-Cong Chang. Collected Commentaries of the Yellow Emperor 's Inner Canon (Huang Di Nei Jing Su Wen Ji Zhu). Taipei: Wen-Kuang Publishing Company. 1982, pp.2, 3, 24, 71, 100, 135, 169-170.
19. Riis, B.J. Biochemical markers of bone turnover II: diagnosis, prophylaxis, and treatment of osteoporosis. Am. J Med. 95(suppl. Sa): 17s-21s, 1993.
20. Shen, Zi-Yin and Wei-Jian Wang. Traditional medicine vacuity pattern identification criteria. Chinese J. of Integrated Traditional & Western Med. 6(10): 598, 1986.
21. Tohme, J.F., S.J. Silverberg and R. Lindsay. Osteoporosis. in: Principles and Practice of Endocrinology and Metabolism. K.L. Becker (ed). Philadelphia: J.B. Lippincott, 1990, pp. 491-504.
22. Turner, R.T., B.L. Riggs and T.C. Spellsberg. Skeletal effects of estrogen. Endocrine Rev. 15: 275-299,1994.
23. Wark J.D. Osteoporosis: pathogenesis, diagnosis, prevention and management. In: Bailliere's Clinical Endocrinology and Metabolism. H.G. Burger(ed-). London: W.B. Saunders, 1993, Chapter?, pp.151-181.
24. William, D.O. and H. Hunter III. Osteoporosis: pathophysiology, prevention, diagnosis, and treatment. Disease-a-Month, XXXI(ll): 809-811,1993.
25. Zhou, Wenquan, Wang Wei and Huo Yu Wei. Experimental screening procedures and norms of clinical observation of herbal medicine for retarding aging process. Chinese J. of Integrated Traditional & Western Med. 6(11): 682-684, 1986.